Atlas Trials

Nuvalent Inc.

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Nuvalent Inc.

RecordFirmDate
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC (NCT06765109)Nuvalent Inc.2025-07-17
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1) (NCT06521554)Nuvalent Inc.2024-07-18
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1) (NCT05384626)Nuvalent Inc.2022-06-09
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1) (NCT05118789)Nuvalent Inc.2022-01-04

Track Nuvalent Inc. automatically

Every clearance here is in the API, with alerts when new ones post.